Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients

Employee's State Insurance Corporation, New Delhi45 enrolled

Overview

All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be studied in accordance with age, sex, duration , type of surgery, site of surgery and BMI.The volume consumption of sevoflurane is compared with Chronic Obstructive Pulmonary Disease and Normal Patients .

Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record

Study Type

OBSERVATIONAL

Enrollment

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

CapnographyDEVICE

To know the Co2 graph in COPD and Normal patients under General Anesthesia

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Both Sex All Age Group Patient willing to give consent COPD patient Exclusion Criteria: * Not willing to give consent Cancerous Lung Lung Lobectomy

Outcomes

Primary Outcomes

Estimation of Volume consumption of Sevoflurane

The consumption is expressed in Volume ml/kg

Time frame: 8 weeks

Central Contacts

Santhosh Kumar T N, BSc

CONTACT

6366470104 tumakuru572102@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.